Srinivas Vourganti to Kidney Neoplasms
This is a "connection" page, showing publications Srinivas Vourganti has written about Kidney Neoplasms.
Connection Strength
2.397
-
Metastasis-directed treatment in kidney cancer. Curr Opin Urol. 2023 09 01; 33(5):375-382.
Score: 0.813
-
Optimizing waiting duration for renal transplants in the setting of renal malignancy: is 2?years too long to wait? Nephrol Dial Transplant. 2017 Oct 01; 32(10):1767-1773.
Score: 0.546
-
Surgical management of large renal tumors. Expert Rev Anticancer Ther. 2011 Dec; 11(12):1889-900.
Score: 0.364
-
The metastatic potential of renal tumors: Influence of histologic subtypes on definition of small renal masses, risk stratification, and future active surveillance protocols. Urol Oncol. 2017 04; 35(4):153.e15-153.e20.
Score: 0.131
-
Re: Csaba Berczi, Ben Thomas, Zsolt Bacso, Tibor Flasko. Bilateral renal cancers: oncological and functional outcomes. Int Urol Nephrol 2016 (Epub ahead of print). Int Urol Nephrol. 2017 Feb; 49(2):267-268.
Score: 0.128
-
Chromophobe Renal Cell Carcinoma is the Most Common Nonclear Renal Cell Carcinoma in Young Women: Results from the SEER Database. J Urol. 2016 Apr; 195(4 Pt 1):847-51.
Score: 0.120
-
Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management. J Clin Oncol. 2014 Feb 10; 32(5):431-7.
Score: 0.105
-
Pathologic validation of renal cell carcinoma histology in the Surveillance, Epidemiology, and End Results program. Urol Oncol. 2014 Jan; 32(1):23.e9-13.
Score: 0.099
-
Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma. BJU Int. 2012 Jun; 109(11):1600-6.
Score: 0.092